Zobrazeno 1 - 10
of 2 413
pro vyhledávání: '"HFREF"'
Autor:
Andrew Sherwood, James A. Blumenthal, Robert J. Mentz, Gary G. Koch, Joseph G. Rogers, Patricia P. Chang, Christopher Chien, Kirkwood F. Adams Jr, Lisa J. Rose‐Jones, Brian C. Jensen, Mark Donahue, Kristy S. Johnson, Alan L. Hinderliter
Publikováno v:
ESC Heart Failure, Vol 11, Iss 5, Pp 2627-2636 (2024)
Abstract Aims The objective of this study was to examine associations between elevated depressive symptoms and increased risk of adverse clinical events patients with heart failure and reduced ejection fraction (HFrEF), as well as the potential contr
Externí odkaz:
https://doaj.org/article/7bf45c289a534adc9e5b848c2edafdfe
Publikováno v:
Cardiologia Hungarica, Vol 54, Iss 5, Pp 378-380 (2024)
We present the case of a 52-year-old female patient on optimal medical therapy (OMT) for heart failure with severely reduced ejection fraction. She was diagnosed with dextrocardia and congenital corrected transposition of the great arteries (ccTGA) b
Externí odkaz:
https://doaj.org/article/5eeccccd02184819bc06a0b1a5dcea3e
Autor:
Dhrumil Patil, Hsin‐Ju Tang, Fang‐Hsiu Kuo, Han Siong Toh, I‐Ning Yang, Wei‐Ting Chang, Mei‐Chuan Lee, Kai‐Ning Chung, Chi‐Ya Huang, Wan‐Hsuan Hsu, Ting‐Chia Chang, Jhih‐Yuan Shih, Chia‐Te Liao
Publikováno v:
ESC Heart Failure, Vol 11, Iss 4, Pp 1963-1970 (2024)
Abstract Aims Heart failure with reduced ejection fraction (HFrEF) significantly impacts health‐related quality of life (HR‐QoL). Existing HR‐QoL questionnaires can show inconsistencies, potentially misrepresenting patient self‐reports. This
Externí odkaz:
https://doaj.org/article/44883dc113e44bbfaa2fb6cf48a780f6
Autor:
Stephen J. Greene, Hanna K. Gaggin, Mo Zhou, Lori D. Bash, Dominik Lautsch, Laurence Djatche, Yan Song, James Signorovitch, Andra S. Stevenson, Robert O. Blaustein, Javed Butler
Publikováno v:
ESC Heart Failure, Vol 11, Iss 4, Pp 1932-1946 (2024)
Abstract Aims Patients with HFrEF and worsening HF events (WHFE) are at particularly high risk and urgently need disease‐modifying therapy. CHART‐HF assessed treatment patterns and reasons for medication decisions among HFrEF patients with and wi
Externí odkaz:
https://doaj.org/article/fd262287325f47009eb6cbad8faee8cd
Autor:
Orsolya Timár
Publikováno v:
Cardiologia Hungarica, Vol 54, Iss 3, Pp 183-192 (2024)
The American College of Cardiology Solution Set Oversight Committee issued an expert consensus document pathway in March, 2024 to aid the clinical decision-making of physicians participating in the care of heart failure patients with reduced ejection
Externí odkaz:
https://doaj.org/article/b6c0def38d144bc3bd27c28bf1882df0
Autor:
Gáspár Dániel, Komlósi Ferenc, Bohus Gyula, Tóth Patrik, Sax Balázs, Heltai Krisztina, Vándor László, Becker Dávid, Merkely Béla, Nagy Klaudia Vivien
Publikováno v:
Cardiologia Hungarica, Vol 54, Iss 3, Pp 234-242 (2024)
Introduction: The use of machine learning is exploding in all areas of healthcare, including the diagnosis and treatment of heart failure. Supervised machine learning can help predict the onset of heart failure, establish the diagnosis, and even pred
Externí odkaz:
https://doaj.org/article/be31ed781df2498ea04d85c78811a759
Publikováno v:
International Journal of Cardiology. Cardiovascular Risk and Prevention, Vol 23, Iss , Pp 200351- (2024)
Background: Heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF) are challenging conditions to treat due to complex pathophysiology and associated comorbidities. However, recent trials have d
Externí odkaz:
https://doaj.org/article/b6223152d7d946f8b7c8d06ceade7c41
Autor:
Łukasz Wołowiec, Daniel Rogowicz, Jacek Budzyński, Joanna Banach, Anna Wołowiec, Mariusz Kozakiewicz, Maciej Bieliński, Albert Jaśniak, Joanna Osiak, Grzegorz Grześk
Publikováno v:
Annals of Medicine, Vol 56, Iss 1 (2024)
AbstractBackground This is the first study to examine the clinical utility of measuring plasma secretoneurin (SN) levels in patients with heart failure with reduced ejection fraction (HFrEF), as a predictor of unplanned hospitalization, and all-cause
Externí odkaz:
https://doaj.org/article/816dc786ae2a495d8ee7ad8b527c0d49
Autor:
Michele Correale, Damiano D’Alessandro, Lucia Tricarico, Vincenzo Ceci, Pietro Mazzeo, Raffaele Capasso, Salvatore Ferrara, Massimo Barile, Nicola Di Nunno, Luciano Rossi, Antonio Vitullo, Michele Granatiero, Mattia Granato, Massimo Iacoviello, Natale Daniele Brunetti
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 54, Iss , Pp 101492- (2024)
Background: Cardiac remodeling is an adverse phenomenon linked to heart failure (HF) progression. Cardiac remodeling could represent the real therapeutic goal in the treatment of patients with HF and reduced ejection fraction (HFrEF), being potential
Externí odkaz:
https://doaj.org/article/eb5dd89b2f8547ad8bd2f0ee8fbd728e
Autor:
Xin Gong, Yuheng Jiao, Hao Hu, Rongzhen Zhang, Wenwen Jia, Jun Zhao, Zhongmin Liu, Yuanfeng Xin, Wei Han
Publikováno v:
Contemporary Clinical Trials Communications, Vol 41, Iss , Pp 101350- (2024)
Background and objective: The use of mesenchymal stem cells for heart failure treatment has gained increasing interest. However, most studies have relied on a single injection approach, with no research yet confirming the effects of multiple administ
Externí odkaz:
https://doaj.org/article/e7a2ced501f54acf9deb0bb8350e5003